Send us Feedback

Takeda Pharmaceutical (TKPHF)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Takeda shutters Bay Area R&D shop in California shakeup
FierceBiotech  May 22  Comment 
Five months after Takeda announced it was formally integrating its R&D efforts in South San Francisco and San Diego into a single entity, the Japanese pharma company dropped the news that it will now shutter its Bay Area ops and move its most...
[$] Takeda Open to More Deals
Wall Street Journal  May 15  Comment 
After spending nearly $15 billion on overseas acquisitions in less than two years, Japan's top drug maker Takeda Pharmaceutical is not ruling out further deals as it looks to overcome patent expiries and cement its position as a global industry...
Lundbeck soars on PhIII success for blockbuster hopeful
FierceBiotech  May 14  Comment 
Lundbeck shares spiked 9% this morning on the news that three late-stage studies of its new depression drug had delivered the data needed to support upcoming regulatory filings. The developer badly needs new therapeutics to replace Lexapro, an...
Sales-needy Takeda springs for emerging markets growth
FiercePharma  May 14  Comment 
Takeda Pharmaceuticals hopes to ease its suffering with a little emerging markets medicine. Investors certainly hope the remedy works: The Japanese company reported a 28% drop in fiscal-year profits and forecasted a 40% drop in sales for the...




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Isaac Middendorf

No more s***. All posts of this qaultiy from now on

Retrieved from "http://www.wikinvest.com/stock/Takeda_Pharmaceutical_(TKPHF)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki